(8-022) Management of Hepatorenal Syndrome with Terlipressin and Albumin Is Associated with Improved Model for End-Stage Liver Disease (MELD) 3.0 Scores in Responders
Tuesday, December 10, 2024
2:00 PM – 3:30 PM
Location: Hall G, Lower Level
Category: Evaluative Study Topic: Clinical Topics/Therapeutics
Co-Author(s): Sarah Nasser, Randolph Regal, Pratima Sharma, Karin Durant
